- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
Treats Adults
Francesco Franchi, MD
Cardiologist
- Additional languages:
- Italian
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 84 publications
- Percutaneous Coronary Intervention , 50 publications
- Purinergic P2Y Receptor Antagonists , 43 publications
- Clopidogrel , 36 publications
Research activity
Active clinical trials
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
149 publications
2026
Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI
Clinical and Translational Science
Publisher's site2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
Clinical Pharmacology & Therapeutics
Publisher's site2026
Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome
JACC: Cardiovascular Interventions
Publisher's site2026
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y12 Inhibitor Therapy
JACC: Advances
Publisher's site2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapy.
Expert review of clinical pharmacology
PubMed • Publisher's site